Retatrutide Once Weekly for Treatment of Obstructive Sleep Apnea. (PubMed, N Engl J Med) - Oct 23, 2026 - P3 | "In adults with OSA and obesity or overweight with or without type 2 diabetes, retatrutide resulted in significantly greater decreases in the AHI than placebo. (Funded by Eli Lilly; TRIUMPH-1 and -2 ClinicalTrials.gov numbers, NCT05929066 and NCT05929079.)."
Journal • Diabetes • Genetic Disorders • Metabolic Disorders • Obesity • Obstructive Sleep Apnea • Respiratory Diseases • Sleep Disorder • Type 2 Diabetes Mellitus
|
|
; Ali Azarbarzin; Atul Malhotra; Beverly L Falcon; Brendan P Lucey; Jitong Lou; Kathryn Giblin; Kathryn Krueger; Ronald R Grunstein; Scott A Sands; Sheryl E Allen; So Young Park; Virend K Somers
|